These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 28664726)
1. Ex Vivo and in Vivo Evaluation of the Effect of Coating a Coumarin-6-Labeled Nanostructured Lipid Carrier with Chitosan-N-acetylcysteine on Rabbit Ocular Distribution. Liu D; Li J; Cheng B; Wu Q; Pan H Mol Pharm; 2017 Aug; 14(8):2639-2648. PubMed ID: 28664726 [TBL] [Abstract][Full Text] [Related]
2. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular. Li J; Tan G; Cheng B; Liu D; Pan W Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370 [TBL] [Abstract][Full Text] [Related]
3. A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin. Li J; Liu D; Tan G; Zhao Z; Yang X; Pan W Carbohydr Polym; 2016 Aug; 146():435-44. PubMed ID: 27112894 [TBL] [Abstract][Full Text] [Related]
4. Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin. Liu D; Li J; Pan H; He F; Liu Z; Wu Q; Bai C; Yu S; Yang X Sci Rep; 2016 Jun; 6():28796. PubMed ID: 27350323 [TBL] [Abstract][Full Text] [Related]
5. Chitosan oligosaccharide enhances binding of nanostructured lipid carriers to ocular mucins: Effect on ocular disposition. Pai RV; Vavia PR Int J Pharm; 2020 Mar; 577():119095. PubMed ID: 32004680 [TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery. Noor NM; Sheikh K; Somavarapu S; Taylor KMG Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472 [TBL] [Abstract][Full Text] [Related]
7. Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery. Tian B; Luo Q; Song S; Liu D; Pan H; Zhang W; He L; Ma S; Yang X; Pan W J Pharm Sci; 2012 Mar; 101(3):1040-9. PubMed ID: 22102480 [TBL] [Abstract][Full Text] [Related]
8. Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system. Luo Q; Zhao J; Zhang X; Pan W Int J Pharm; 2011 Jan; 403(1-2):185-91. PubMed ID: 20951778 [TBL] [Abstract][Full Text] [Related]
9. Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis. Ustündağ-Okur N; Gökçe EH; Bozbıyık Dİ; Eğrilmez S; Ozer O; Ertan G Eur J Pharm Sci; 2014 Oct; 63():204-15. PubMed ID: 25111119 [TBL] [Abstract][Full Text] [Related]
10. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues. Balguri SP; Adelli GR; Majumdar S Eur J Pharm Biopharm; 2016 Dec; 109():224-235. PubMed ID: 27793755 [TBL] [Abstract][Full Text] [Related]
11. Nanostructured lipid carriers-based thermosensitive eye drops for enhanced, sustained delivery of dexamethasone. Mo Z; Ban J; Zhang Y; Du Y; Wen Y; Huang X; Xie Q; Shen L; Zhang S; Deng H; Hou D; Chen Y; Lu Z Nanomedicine (Lond); 2018 Jun; 13(11):1239-1253. PubMed ID: 29949466 [TBL] [Abstract][Full Text] [Related]
12. Penetration of Nile red-loaded nanostructured lipid carriers (NLCs) across the porcine cornea. Niamprem P; Srinivas SP; Tiyaboonchai W Colloids Surf B Biointerfaces; 2019 Apr; 176():371-378. PubMed ID: 30658285 [TBL] [Abstract][Full Text] [Related]
13. The potential application of hyaluronic acid coated chitosan nanoparticles in ocular delivery of dexamethasone. Kalam MA Int J Biol Macromol; 2016 Aug; 89():559-68. PubMed ID: 27164496 [TBL] [Abstract][Full Text] [Related]
14. The role of chitosan as coating material for nanostructured lipid carriers for skin delivery of fucoxanthin. Malgarim Cordenonsi L; Faccendini A; Catanzaro M; Bonferoni MC; Rossi S; Malavasi L; Platcheck Raffin R; Scherman Schapoval EE; Lanni C; Sandri G; Ferrari F Int J Pharm; 2019 Aug; 567():118487. PubMed ID: 31271813 [TBL] [Abstract][Full Text] [Related]
15. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
16. Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome. Tan G; Li J; Song Y; Yu Y; Liu D; Pan W Acta Biomater; 2019 Nov; 99():350-362. PubMed ID: 31449929 [TBL] [Abstract][Full Text] [Related]
17. Ex vivo and In vivo Evaluation of Chitosan Coated Nanostructured Lipid Carriers for Ocular Delivery of Acyclovir. Seyfoddin A; Sherwin T; Patel DV; McGhee CN; Rupenthal ID; Taylor JA; Al-Kassas R Curr Drug Deliv; 2016; 13(6):923-34. PubMed ID: 26568139 [TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability. Liu R; Liu Z; Zhang C; Zhang B J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401 [TBL] [Abstract][Full Text] [Related]
19. Augmented ocular uptake and anti-inflammatory efficacy of decorated Genistein-loaded NLCs incorporated in in situ gel. Elmanawy MA; Boraie N; Bakr BA; Makled S Int J Pharm; 2024 Sep; 662():124508. PubMed ID: 39053680 [TBL] [Abstract][Full Text] [Related]
20. Preparation of Chitosan-Coated Nanostructured Lipid Carriers (CH-NLCs) to Control Iron Delivery and Their Potential Application to Food Beverage System. Lee SA; Joung HJ; Park HJ; Shin GH J Food Sci; 2017 Apr; 82(4):904-912. PubMed ID: 28241098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]